At such a time, in RGZ-treated tumours, the number of caspase-3 immunopositive cells was significantly lower (P<0.05) and necrotic areas were less extended than in solvent-treated tumours (Table 1 and Figure 3B). This evidence concerns the gene CASP3 and neoplasm.